K George Chandy Selected Research

Kv1.3 Potassium Channel

11/2006

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K George Chandy Research Topics

Disease

11	Autoimmune Diseases (Autoimmune Disease) 08/2020 - 09/2003
9	Multiple Sclerosis 01/2021 - 06/2004
7	Neoplasms (Cancer) 02/2022 - 07/2012
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2012 - 08/2005
3	Hypersensitivity (Allergy) 09/2012 - 01/2007
3	Rheumatoid Arthritis 09/2012 - 11/2006
2	Neuroinflammatory Diseases 12/2023 - 01/2023
2	Metabolic Diseases (Metabolic Disease) 01/2020 - 01/2019
2	Heart Diseases (Heart Disease) 01/2020 - 01/2002
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 03/2013
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2017 - 01/2017
2	Arthritis (Polyarthritis) 09/2012 - 11/2006
1	Rupture 12/2023
1	Hypoxia (Hypoxemia) 09/2022
1	Colonic Neoplasms (Colon Cancer) 02/2022
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Pain (Aches) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Brain Injuries (Brain Injury) 04/2014
1	Insulin Resistance 06/2013
1	Fatty Liver 06/2013
1	Weight Gain 06/2013
1	Melanoma (Melanoma, Malignant) 07/2012
1	Demyelinating Diseases (Demyelinating Disease) 01/2011
1	Opportunistic Infections (Opportunistic Infection) 08/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2008
1	Atherosclerosis 09/2008
1	Chronic Disease (Chronic Diseases) 01/2007
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2006
1	Diabetes Mellitus 11/2006
1	Cardiotoxicity 04/2005
1	Body Weight (Weight, Body) 06/2004
1	Cerebellar Ataxia (Dysmetria) 02/2004
1	Hyperplasia 09/2003
1	Heart Block 01/2002
1	Hereditary bundle branch system defect 01/2002

Drug/Important Bio-Agent (IBA)

7	Peptides (Polypeptides)IBA 01/2023 - 04/2005
4	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2023 - 01/2002
4	AntigensIBA 08/2020 - 01/2007
3	Ion Channels (Ion Channel)IBA 01/2020 - 01/2002
3	PotassiumIBA 01/2016 - 04/2014
3	Potassium Channels (Potassium Channel)IBA 08/2009 - 12/2005
2	EnzymesIBA 09/2022 - 01/2011
2	CholesterolIBA 06/2013 - 09/2008
2	pristane (pristan)IBA 09/2012 - 11/2006
2	5-(4-phenylbutoxy)psoralenIBA 07/2012 - 06/2004
2	Immunologic Factors (Immunomodulators)IBA 03/2012 - 06/2004
2	TRAM 34IBA 09/2008 - 09/2003
2	AutoantigensIBA 10/2007 - 06/2004
2	Myelin Basic ProteinIBA 10/2007 - 01/2007
1	Adenosine (Adenocard)FDA LinkGeneric 09/2022
1	Adenosine Triphosphate (ATP)IBA 09/2022
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 02/2022
1	Immune Checkpoint InhibitorsIBA 02/2022
1	CalciumIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	PlatinumIBA 01/2018
1	SugarsIBA 06/2013
1	Insulin (Novolin)FDA Link 06/2013
1	LeptinIBA 06/2013
1	Proteins (Proteins, Gene)FDA Link 03/2013
1	Therapeutic UsesIBA 09/2012
1	Clofazimine (Lamprene)FDA Link 07/2012
1	Myelin-Oligodendrocyte GlycoproteinIBA 06/2012
1	ShK neurotoxinIBA 03/2012
1	Polysaccharides (Glycans)IBA 01/2011
1	Cholecalciferol (Vitamin D3)FDA Link 01/2011
1	Interleukin-7 (Interleukin 7)IBA 01/2011
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2011
1	CTLA-4 AntigenIBA 01/2011
1	Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA 09/2008
1	Clotrimazole (Lotrimin)FDA LinkGeneric 09/2008
1	Apolipoproteins E (ApoE)IBA 09/2008
1	EmulsionsIBA 01/2007
1	Kv1.3 Potassium ChannelIBA 11/2006
1	Neuroprotective AgentsIBA 02/2004
1	Riluzole FDA LinkGeneric 02/2004
1	CollagenIBA 09/2003
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 09/2003
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 09/2003

Therapy/Procedure

15	Therapeutics 01/2020 - 09/2003
3	Immunomodulation 01/2019 - 04/2005
1	Immunotherapy 01/2017
1	Radiotherapy 04/2014
1	Intraperitoneal Injections 07/2012
1	Subcutaneous Injections 06/2004
1	Catheters 09/2003